Laboratory Corp of America Holdings (LH) - Financial and Strategic SWOT Analysis Review

Date: March 28, 2017
Pages: 59
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L263FF2C92FEN
Leaflet:

Download PDF Leaflet

Laboratory Corp of America Holdings (LH) - Financial and Strategic SWOT Analysis Review
Laboratory Corp of America Holdings (LH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. It also offers drug development services through Covance. It offers its services to managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies through a network of primary laboratories and patient service centers. The company has operations across the US, Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

Laboratory Corp of America Holdings Key Recent Developments

Mar 29,2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company’s Two Primary Business Segments
Feb 16,2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance
Oct 26,2016: Laboratory Corporation of America Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance
Oct 25,2016: Covance Central Laboratory Services Ranks No. 1 in Global Investigator Satisfaction for the Third Consecutive Time
Oct 12,2016: Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Laboratory Corp of America Holdings - Key Facts
Laboratory Corp of America Holdings - Key Employees
Laboratory Corp of America Holdings - Key Employee Biographies
Laboratory Corp of America Holdings - Major Products and Services
Laboratory Corp of America Holdings - Medical Equipment Pipeline Products Data
Laboratory Corp of America Holdings Pipeline Products by Equipment Type
Laboratory Corp of America Holdings Pipeline Products by Development Stage
Laboratory Corp of America Holdings - History
Laboratory Corp of America Holdings - Company Statement
Laboratory Corp of America Holdings - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Laboratory Corp of America Holdings - Business Description
Laboratory Corp of America Holdings - Corporate Strategy
Laboratory Corp of America Holdings - SWOT Analysis
SWOT Analysis - Overview
Laboratory Corp of America Holdings - Strengths
Laboratory Corp of America Holdings - Weaknesses
Laboratory Corp of America Holdings - Opportunities
Laboratory Corp of America Holdings - Threats
Laboratory Corp of America Holdings - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2011 to YTD 2017
Laboratory Corp of America Holdings, Medical Equipment, Deals By Type, 2011 to YTD 2017
Laboratory Corp of America Holdings, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance
Oct 26, 2016: Laboratory Corporation of America Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance
Oct 25, 2016: Covance Central Laboratory Services Ranks No. 1 in Global Investigator Satisfaction for the Third Consecutive Time
Oct 12, 2016: Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running
Oct 03, 2016: Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation
Sep 20, 2016: LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development
Sep 01, 2016: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation
Aug 23, 2016: DECN Litigation Victory Against Johnson + Johnson, Launches Foothold in On-Line Retail Markets for Its Popular 'Gen' Products
Jul 27, 2016: Laboratory Corporation of America Holdings Announces 2016 Second Quarter Results and Raises 2016 Guidance
Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Laboratory Corp of America Holdings, Key Facts
Laboratory Corp of America Holdings, Key Employees
Laboratory Corp of America Holdings, Key Employee Biographies
Laboratory Corp of America Holdings, Major Products and Services
Laboratory Corp of America Holdings Pipeline Products by Equipment Type
Laboratory Corp of America Holdings Number of Pipeline Products by Development Stage
Laboratory Corp of America Holdings Pipeline Products Summary by Development Stage
Laboratory Corp of America Holdings, History
Laboratory Corp of America Holdings, Other Locations
Laboratory Corp of America Holdings, Subsidiaries
Laboratory Corp of America Holdings, Key Competitors
Laboratory Corp of America Holdings, Ratios based on current share price
Laboratory Corp of America Holdings
Laboratory Corp of America Holdings (Cont.1)
Laboratory Corp of America Holdings, Interim Ratios
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2011 to YTD 2017
Laboratory Corp of America Holdings, Medical Equipment, Deals By Type, 2011 to YTD 2017
Laboratory Corp of America Holdings, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Laboratory Corp of America Holdings Pipeline Products by Equipment Type
Laboratory Corp of America Holdings Pipeline Products by Development Stage
Laboratory Corp of America Holdings, Performance Chart (2012 - 2016)
Laboratory Corp of America Holdings, Ratio Charts
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2011 to YTD 2017
Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sonic Healthcare Ltd
Quintiles IMS Holdings Inc
Quest Diagnostics Inc
Pharmaceutical Product Development LLC
Parexel International Corp
INC Research Holdings Inc
ICON Plc
Genomic Health Inc
Cord Blood America Inc
Clarient Inc
Charles River Laboratories International Inc
Bio-Reference Laboratories Inc
Skip to top


Ask Your Question

Laboratory Corp of America Holdings (LH) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: